Ann Intern Med:中国全新肥胖地图:京津冀人最胖!天津人腰最粗

2019-10-30 卢芳 中国循环杂志

近日,中国疾控中心进行的研究显示,2004~2014年,国人肥胖患病率增长了3倍多,腹型肥胖患病率增长了50%多。

生活好了,“富态”的人就不知不觉多了。
 
近日,中国疾控中心进行的研究显示,2004~2014年,国人肥胖患病率增长了3倍多,腹型肥胖患病率增长了50%多。
 
2004年时,肥胖患病率为3.3%,腹型肥胖为25.9%,而到2014年,则分别激增为14.0%和31.5%。
 
研究者还发现,不同地儿肥胖患病率不同,整体来看北方较为流行,其中京津冀大都市区是肥胖重灾区。
 
以北京为例,北京居民的肥胖患病率是海南居民的6倍(26.6% vs 4.4%)。
 
就男女而言,京津冀大都市区、黑龙江、新疆的男士肥胖患病率最高,这种分布在女士也一样。
 
天津的居民们“腰最粗”,女士腹型肥胖患病率率达49.4%,而广西省的女士们仅17.7%;男士腹型肥胖患病率达54.4%,而海南省的男士仅16.5%。

新疆、西藏和内蒙古的女士们腰也不细。
 


注:A:男性肥胖加权患病率;B:女性肥胖加权患病率;C:男性腹型肥胖加权患病率;B:女性腹型肥胖加权患病率

图1 全国31个省级行政区男性和女性肥胖和腹型肥胖的分布情况
 
如果以世界卫生组织和美国国家心肺血研究所制定的阈值评估,肥胖患病率为6.3%,腹型肥胖患病率为14.4%。
 
这远轻于美国的肥胖“灾情”:男士肥胖患病率为35.4%,女士为61.5%。
 
肥胖是撬动高血压糖尿病、心力衰竭、癌症等发生的一个“支点”,如果不能有效遏制其广泛流行,就意味着心血管病等慢性病发病率的全面“飘红”。
 
北卡罗来纳大学教堂山吉林斯全球公共卫生学院Penny Gordon-Larsen认为,中国肥胖的流行与城市化进程息息相关,中国糖尿病高血压患病率的增加背后都有“肥胖”做推手。
 
她指出,中国儿童肥胖患病率也在不断增加,这些都将对中国社会和医疗系统带来巨大挑战。
 
Gordon-Larsen强调,肥胖对于亚洲人,尤其是中国人,特别是腹型肥胖对健康“更坏事”。
 
研究者指出,这项研究显示的肥胖的区域性差异和性别差异提示,应进一步对肥胖流行的环境进行深入研究,以对特定区域和性别进行有的放矢的干预。
 
我国也极为重视慢病及其危险因素的流行。
 
“健康中国2030”强调维护全生命周期健康,并制定了15项具体行动,以倡导健康生活方式的普及,遏制肥胖等的流行,降低重大慢性病过早死亡率,增长人均健康预期寿命,并使得居民主要健康指标水平进入高收入国家行列。
 
在这项研究中,研究者应用2013~2014年中国慢病和危险因素监测数据库的数据进行了分析。
 
2004年数据,肥胖定义为BMI≥30 kg/m2,腹型肥胖定义为男性腰围≥90 cm,女性腰围≥80 cm;2014年数据,肥胖定义为≥28 kg/m2,腹型肥胖定义为男性腰围≥90 cm,女性腰围≥85 cm。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1659913, encodeId=452b165991399, content=<a href='/topic/show?id=ae13245e16c' target=_blank style='color:#2F92EE;'>#京津冀#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24571, encryptionId=ae13245e16c, topicName=京津冀)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e7e25082405, createdName=achengzhao, createdTime=Wed Sep 30 01:25:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610070, encodeId=2bad16100e0e2, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 31 17:25:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374600, encodeId=f6bd3e460038, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/28/bf08ae68063ce2655d131c9750dca493.jpg, createdBy=aa9a5216866, createdName=z6125, createdTime=Wed Oct 30 18:28:33 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374586, encodeId=62063e458666, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Wed Oct 30 07:00:56 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374584, encodeId=f92c3e4584e2, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Wed Oct 30 06:47:56 CST 2019, time=2019-10-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1659913, encodeId=452b165991399, content=<a href='/topic/show?id=ae13245e16c' target=_blank style='color:#2F92EE;'>#京津冀#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24571, encryptionId=ae13245e16c, topicName=京津冀)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e7e25082405, createdName=achengzhao, createdTime=Wed Sep 30 01:25:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610070, encodeId=2bad16100e0e2, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 31 17:25:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374600, encodeId=f6bd3e460038, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/28/bf08ae68063ce2655d131c9750dca493.jpg, createdBy=aa9a5216866, createdName=z6125, createdTime=Wed Oct 30 18:28:33 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374586, encodeId=62063e458666, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Wed Oct 30 07:00:56 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374584, encodeId=f92c3e4584e2, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Wed Oct 30 06:47:56 CST 2019, time=2019-10-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1659913, encodeId=452b165991399, content=<a href='/topic/show?id=ae13245e16c' target=_blank style='color:#2F92EE;'>#京津冀#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24571, encryptionId=ae13245e16c, topicName=京津冀)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e7e25082405, createdName=achengzhao, createdTime=Wed Sep 30 01:25:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610070, encodeId=2bad16100e0e2, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 31 17:25:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374600, encodeId=f6bd3e460038, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/28/bf08ae68063ce2655d131c9750dca493.jpg, createdBy=aa9a5216866, createdName=z6125, createdTime=Wed Oct 30 18:28:33 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374586, encodeId=62063e458666, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Wed Oct 30 07:00:56 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374584, encodeId=f92c3e4584e2, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Wed Oct 30 06:47:56 CST 2019, time=2019-10-30, status=1, ipAttribution=)]
    2019-10-30 z6125

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1659913, encodeId=452b165991399, content=<a href='/topic/show?id=ae13245e16c' target=_blank style='color:#2F92EE;'>#京津冀#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24571, encryptionId=ae13245e16c, topicName=京津冀)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e7e25082405, createdName=achengzhao, createdTime=Wed Sep 30 01:25:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610070, encodeId=2bad16100e0e2, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 31 17:25:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374600, encodeId=f6bd3e460038, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/28/bf08ae68063ce2655d131c9750dca493.jpg, createdBy=aa9a5216866, createdName=z6125, createdTime=Wed Oct 30 18:28:33 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374586, encodeId=62063e458666, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Wed Oct 30 07:00:56 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374584, encodeId=f92c3e4584e2, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Wed Oct 30 06:47:56 CST 2019, time=2019-10-30, status=1, ipAttribution=)]
    2019-10-30 qingfengqishi5

    学习了,学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1659913, encodeId=452b165991399, content=<a href='/topic/show?id=ae13245e16c' target=_blank style='color:#2F92EE;'>#京津冀#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24571, encryptionId=ae13245e16c, topicName=京津冀)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e7e25082405, createdName=achengzhao, createdTime=Wed Sep 30 01:25:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610070, encodeId=2bad16100e0e2, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 31 17:25:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374600, encodeId=f6bd3e460038, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/28/bf08ae68063ce2655d131c9750dca493.jpg, createdBy=aa9a5216866, createdName=z6125, createdTime=Wed Oct 30 18:28:33 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374586, encodeId=62063e458666, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Wed Oct 30 07:00:56 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374584, encodeId=f92c3e4584e2, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Wed Oct 30 06:47:56 CST 2019, time=2019-10-30, status=1, ipAttribution=)]
    2019-10-30 txqjm

    谢谢了,学习

    0

相关资讯

三成国人腹型肥胖!中国44万居民调查结果

中国医学科学院阜外医院高润霖院士等研究发现,我国29.1%居民为腹型肥胖,其中男性为28.6%,女性为29.6%。

因肥丧命!肥胖让人平均减寿3年,儿童和青少年受影响最恶劣

经济合作与发展组织(OECD)发布最新报告《肥胖重负:预防经济学》(以下简称《肥胖重负》)称,世界多国急需“瘦身”。若不加以控制,到2050年,世界发达国家、富裕地区的人均寿命,或将减少3年,可能有9000万人“因肥丧命”。

BBC:我们为什么变得这么胖?解开你的不瘦之谜

如此严峻的肥胖问题背后的原因是什么呢?

岁月催人老,熬夜催人肥

2018年的膘还没减完,又贴上了2019的新秋膘……

Int J Obesity:澳学者称,孩子将来胖不胖,先看妈妈胖不胖和教育程度

根据澳大利亚最新研究,有三个简单的因素可以预测孩子到青春期时是否可能超重或肥胖,除了孩子本身的体重指数(BMI),还包括母亲胖不胖和教育水平。

JCEM:超重和肥胖对儿童和青少年肝脏生化指标的影响

由此可见,小儿肝酶正常值随年龄和性别而变化。超重和肥胖与肝脏损害的生化指标升高有关。这些发现强调了预防和治疗儿童和青少年超重和肥胖的必要性。